RxDoctor Payments Data

Michele Zerah

Pediatric Endocrinology · El Paso, TXNPI 1386660850

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.6% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations.

$1,823in general payments, 2019–2025

Across 49 payments — averaging $37.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$347
  • AstraZeneca$306
  • BETA Bionics, Inc.$162
  • Amgen$127
  • Dexcom, Inc.$124
  • Tolmar, Inc.$117
  • plus $640 from 15 others

What the payments were for

  • Food & beverage$1,67092%
  • Education$1538%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,823 in reported general payments places this provider in the 60th percentile of 120 pediatric endocrinology providers in Texas.

See all pediatric endocrinology providers in Texas

Other pediatric endocrinology in El Paso

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →